Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of ondansetron in treatment of irritable bowel syndrome (IBS)
IRCT20190703044084N2Phase 3Completed
- Sponsor
- Zanjan University of Medical Sciences
- Start
- Jun 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of ondansetron in Diarrhea-predominant irritable bowel syndrome (IBS-D), sponsored by Zanjan University of Medical Sciences. Started Jun 2019; status: completed.
02
Drugs
ondansetron
03
Conditions
Diarrhea-predominant irritable bowel syndrome (IBS-D)
Beyond the preview
Go deeper on IRCT20190703044084N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190703044084N2.